论文信息 - Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study - 字舞流文

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

V. Torri | L. Cortesi | E. Rulli | D. Toniolo | M. Cazzaniga | M. Giordano | M. Nicolini | A. Colombo | I. Marchi | A. Ardizzoia | F. Villa | P. Pugliese | F. Riva | M. Ciccarese | E. Collovà | C. Verusio | E. Biraghi | A. Gambaro | A. Ferzi | L. Scaltriti | L. Zanlorenzi | S. Della Torre | L. Legramandi | L. Stocchi | F. Cicchiello | C. Fasola | G. Prati | F. Galli | Francesca Pelizzoni Isabella Elena Giuseppe Antonio Davide P Riva Davide Marchi Collovà Prati Ardizz | Pelizzoni Davide | C. Pogliani | A. Gambino | R. Venezia